Amy Main
Psychiatric/Mental Health · Winston Salem, NCNPI 1205301710
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,606 of the $6,255 with a category attached, or 89.6%. It is spread thinly across 13 manufacturers, the largest accounting for just 22.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $2,571 and has fallen 68.1% since, to $821 in 2025. Among psychiatric/mental health clinicians in NC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 264 payments — averaging $23.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$1K
- Johnson & Johnson$1K
- Teva Pharmaceuticals USA, Inc.$1K
- AbbVie$861
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$617
- Otsuka America Pharmaceutical, Inc.$448
- plus $848 from 7 others
What the payments were for
- Travel & lodging$3205%
- Food & beverage$5,60690%
- Education$3285%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 58 | $1,382 |
| Johnson & Johnson | 32 | $1,051 |
| Teva Pharmaceuticals USA, Inc. | 56 | $1,048 |
| AbbVie | 46 | $861 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 13 | $617 |
| Otsuka America Pharmaceutical, Inc. | 19 | $448 |
| Neurocrine Biosciences, Inc. | 21 | $363 |
| Vanda Pharmaceuticals Inc. | 6 | $148 |
| E.r. Squibb & Sons, L.L.C. | 1 | $125 |
| Indivior Inc. | 5 | $89 |
| Axsome Therapeutics, Inc. | 4 | $73 |
| Noven Therapeutics, LLC | 2 | $27 |
| Lundbeck LLC | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,255 in reported general payments places this provider in the 90th percentile of 947 psychiatric/mental health providers in North Carolina.
See all psychiatric/mental health providers in North Carolina →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 18 | $128,725 |
| Invega SustennaPaliperidone Palmitate | 32 | $113,236 |
| VraylarCariprazine Hcl | 37 | $57,870 |
| LybalviOlanzapine/Samidorphan Malate | 17 | $26,276 |
| FanaptIloperidone | 12 | $21,535 |
| Lurasidone Hcl | 34 | $15,324 |
| Aripiprazole | 56 | $7,509 |
| TrintellixVortioxetine Hydrobromide | 12 | $6,010 |
| Haloperidol Decanoate | 32 | $3,159 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 53 | $2,753 |
| Paliperidone ErPaliperidone | 34 | $2,569 |
| Divalproex Sodium ErDivalproex Sodium | 45 | $1,905 |
| Ziprasidone Hcl | 18 | $1,477 |
| Ramelteon | 12 | $1,247 |
| Trazodone Hcl | 94 | $893 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $363 | $128,72518 claims |
| Johnson & JohnsonInvega Sustenna | $1,051 | $113,23632 claims |
| AbbVieVraylar | $861 | $57,87037 claims |
| Alkermes, Inc.Lybalvi | $1,382 | $26,27617 claims |
| Vanda Pharmaceuticals Inc.Fanapt | $148 | $21,53512 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 947 psychiatric/mental health providers in North Carolina.
Other psychiatric/mental health in Winston Salem
- Amy CouchWinston Salem$8K
- William GoldingWinston Salem$7K
- Lillykutty ModoorWinston Salem$7K
- Desiree MatthewsCharlotte$807K
- Benedetto PalomboCharlotte$671K
- Clarence RunnelsCreedmoor$339K
- Lisa SuddrethGastonia$111K
- April NandigamGreensboro$88K
- Hannah NealeyFuquay Varina$75K
- Jessica StoneRocky Mount$63K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.